Format
Items per page
Sort by

Send to:

Choose Destination

Links from PubMed

Items: 1 to 20 of 52

1.
2.

Cardiovascular medication prescribing in older adults with psychiatric disorders.

Dolder CR, Veverka A, Nuzum DS, McKinsey J.

Consult Pharm. 2007 Aug;22(8):660-8. Review.

PMID:
18198964
3.

Clinical equivalence of generic and brand-name drugs used in cardiovascular disease: a systematic review and meta-analysis.

Kesselheim AS, Misono AS, Lee JL, Stedman MR, Brookhart MA, Choudhry NK, Shrank WH.

JAMA. 2008 Dec 3;300(21):2514-26. doi: 10.1001/jama.2008.758. Review.

4.

Drug class effects: definitions and practical applications.

Soares I, Carneiro AV.

Rev Port Cardiol. 2002 Sep;21(9):1031-42. Review. English, Portuguese.

5.

Choosing a drug from within a class.

Shakib S, George A.

Aust Fam Physician. 2003 Jun;32(6):438-41. Review.

PMID:
12833771
6.

Generics: what's in a name?

Keith LG, Oleszczuk JJ, Stika CS, Stine S.

Int J Fertil Womens Med. 1998 May-Jun;43(3):139-49. Review.

PMID:
9692536
7.

Generic drugs in cardiology: will they reduce health care costs?

Pitt B.

J Am Coll Cardiol. 2004 Jul 7;44(1):10-3. Review.

8.

Molecular medicine, the Medicare drug benefit, and the need for cost control.

Gillick MR.

J Am Geriatr Soc. 2006 Sep;54(9):1442-6. Review.

PMID:
16970656
9.

Policies to enhance the efficiency of prescribing in the Spanish Catalan region: impact and future direction.

Coma A, Zara C, Godman B, Agustí A, Diogène E, Wettermark B, Haycox A.

Expert Rev Pharmacoecon Outcomes Res. 2009 Dec;9(6):569-81. doi: 10.1586/erp.09.58. Review.

PMID:
19941434
10.

Reforms and initiatives in Scotland in recent years to encourage the prescribing of generic drugs, their influence and implications for other countries.

Godman B, Bishop I, Finlayson AE, Campbell S, Kwon HY, Bennie M.

Expert Rev Pharmacoecon Outcomes Res. 2013 Aug;13(4):469-82. doi: 10.1586/14737167.2013.820956. Review.

PMID:
23977975
11.

Benefits of optimising drug treatment in home-dwelling elderly patients with coronary artery disease.

Strandberg T, Pitkala K, Tilvis R.

Drugs Aging. 2003;20(8):585-95. Review.

PMID:
12795626
12.

[Cardiovascular pharmacotherapy in the aged].

Baumhäkel M, Böhm M.

Internist (Berl). 2003 Aug;44(8):943-50. Review. German.

PMID:
14671808
13.

Generic versus branded pharmacotherapy in Parkinson's disease: does it matter? A review.

Go CL, Rosales RL, Schmidt P, Lyons KE, Pahwa R, Okun MS.

Parkinsonism Relat Disord. 2011 Jun;17(5):308-12. doi: 10.1016/j.parkreldis.2011.02.005. Epub 2011 Mar 1. Review.

PMID:
21367644
14.

The use of generic drugs in prevention of chronic disease is far more cost-effective than thought, and may save money.

Shrank WH, Choudhry NK, Liberman JN, Brennan TA.

Health Aff (Millwood). 2011 Jul;30(7):1351-7. doi: 10.1377/hlthaff.2010.0431. Review.

15.

Generic drugs in dermatology: part I.

Payette M, Grant-Kels JM.

J Am Acad Dermatol. 2012 Mar;66(3):343.e1-8; quiz 351-2. doi: 10.1016/j.jaad.2011.11.944. Review.

PMID:
22342021
16.

Cardiovascular pharmacotherapeutic considerations in patients undergoing anesthesia.

Wolf A, McGoldrick KE.

Cardiol Rev. 2011 Jan-Feb;19(1):12-6. doi: 10.1097/CRD.0b013e3182000e11. Review.

PMID:
21135597
17.

[Me too's and generics].

Gysling E.

Praxis (Bern 1994). 1999 Apr 15;88(16):709-12. Review. German.

PMID:
10355336
19.

Pharmacogenetics of chronic cardiovascular drugs: applications and implications.

Zineh I, Johnson JA.

Expert Opin Pharmacother. 2006 Aug;7(11):1417-27. Review.

PMID:
16859425
20.

Cardiovascular drugs for the newborn.

Ward RM, Lugo RA.

Clin Perinatol. 2005 Dec;32(4):979-97, x. Review. Erratum in: Clin Perinatol. 2006 Jun;33(2):557.

PMID:
16325673
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk